None listed
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion criteria 1. Subject aged 20 years or older 2. Subject who has been diagnosed with chronic hepatitis B (HBs Ag (+) for minimum of 6 months) 3. Subject who is currently under clinical follow-up at the registered institution 4. Subject who has previously undergone or who can undergo liver fibroscan at the time of registration 5. Subject who has given informed consent to the enrollment
Exclusion criteria
Exclusion criteria: Exclusion criteria 1. Subject with decompensated liver cirrhosis or hepatocellular carcinoma at the time of initial liver fibroscan 2. Subject who had previously undergone antiviral therapy for chronic hepatitis B 3. Subject who are concomittantly infected with HCV, HDV or HIV 4. Subject with chronic alcoholism defined as equal to or greater than 40g of alcohol for duration of 5 years or longer 5. Subject who has been diagnosed with right sided heart failure 6. Subjects whose liver fibroscan result is not valid 7. Subject who is considered ineligble by the researcher 8. Subject who is pregnant at the time of registration
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Development of liver-related events | — |
Secondary
| Measure | Time frame |
|---|---|
| Hepatocellular carcinoma | — |
Countries
Korea, Republic of
Contacts
Yonsei University Health System, Severance Hospital